Abstract
Objectives
Apnea diving is characterized by extreme hypoxia and hypercapnia. Possible pathophysiological processes concerning the cardiovascular system are not yet fully understood. Hypoxia has effects on triglyceride metabolism and circulating blood lipids. To date, in voluntary apnea divers, no short-time hypoxia expositions focusing on plasma triglycerides, lipoprotein and cholesterol derived oxysterols levels have been performed. We hypothesize that short time hypoxemia leads to altered triglyceride, cholesterol, and oxysterol plasma levels in voluntary apnea divers.
Methods
Ten athletes performed apnea under dry conditions in a horizontal position. Plasma levels of lipids, lipoproteins and oxysterols were determined with turbidimetric immunoassays, gas chromatography (GC) - flame ionization detection (FID) and GC-MS-SIM before apnea, immediately after apnea and 0.5 h after apnea. All sterols and oxysterols were corrected for GC-FID cholesterol as measured in the same sample. Spearman’s rank correlation test was performed and pairwise comparison of absolute and cholesterol corrected plasma levels from the different sampling dates was conducted using a robust mixed linear model.
Results
We observed significantly reduced levels of apolipoprotein B, triglycerides, cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol, and oxysterols (7β-OHC, 24-OHC, 27-OHC and 7-KC) for different time points. Cholesterol corrected plasma levels of the oxysterols showed no significant changes after short post-apnea time except for a significant elevation of the cholestane-3β, 5α, 6β-triol ratio.
Conclusions
We could observe that a single short time hypoxemia under dry conditions in voluntary apnea divers leads to altered triglyceride, cholesterol and oxysterol plasma levels.
Introduction
During dives, apnea or breath hold divers undergo extreme hypercapnia and hypoxemia [1]. While large inter-individual variations in apneic capabilities exist, the transition from physiological to pathophysiological reactions to apneic diving are often not fully understood [2]. Studies have reported, inter alia, changes in cerebral and peripheral tissue oxygenation as part of the diving response [3], changes in, e.g., hemoglobin and blood cell concentration levels [4] or higher long-term risks for the prevalence of chronic kidney disease [5]. Since apnea diving as a recreational sport is becoming increasingly popular, so will possible associated health risks [2]. Therefore, studies have been initiated to assess possible pathophysiological processes in non-elite apnea divers concerning inflammatory processes and their burden on the cardiovascular system [6], [7], [8]. Hypoxemia as a key point in apnea diving is also a phenomenon seen in illness conditions, such as obstructive sleep apnea (OSA) syndrome [9]. In OSA patients, the risk of developing cardiovascular disease is increased. However, for apneic divers, long term studies are missing [10]. Morin et al. reported that hypoxia may have effects on triglyceride metabolism via production of very low-density lipoproteins (VLDL) and chylomicrons and highlights the effects of hypoxia on circulating blood lipids, especially triglycerides [11]. Morin et al. further reviewed that simulated hypoxia led either to increased or to no differences in triglyceride levels [11]. Hypoxia exposition times of 6 h led to no differences in fasting healthy young men [12, 13], to increased blood triglyceride levels in prandial participants (15%) [14] and in postprandial healthy young men, to higher increased blood triglyceride levels (45%) [15]. In OSA patients, no differences in blood triglyceride levels were observed after a hypoxia exposition time of 6 h [15]. However, no short-time hypoxia expositions, especially with regard to plasma triglycerides, lipoprotein and cholesterol derived oxysterol levels, have been performed in voluntary apnea divers to date. In general, triglycerides are transported within the core of lipoproteins [16]. Postprandially, they are transported with chylomicrons in the intestine and during fasting episodes, the liver secretes VLDL transporting triglycerides [17]. VLDL are inter alia metabolized to low density lipoproteins (LDL) [16]. Hypertriglyceridemia and elevated LDL levels are associated with an increased risk of cardiovascular diseases, especially coronary heart disease and stroke [18]. Autoxidation of cholesterol, e.g., in LDL leads to formation of oxysterols (e.g., 7 ketocholesterol) [19]. Oxysterols are oxygenated derivates of cholesterol and are not only generated via autooxidation, but also via enzymatic formation involving different enzymes [20, 21]. Oxysterols are linked to several biological functions and pathologies, such as cardiovascular, metabolic, and neurodegenerative diseases as well as cancer [22]. Focusing on the cardiovascular pathologies, cholesterol and oxysterols are involved in atherosclerosis, oxidative stress, and inflammatory processes [23]. To date, several investigations based on protein coding messengers and endothelial cell-derived microparticles (EMPs) as well as magnetic resonance imaging have shown that apnea diving could adversely affect the cardiovascular system [6, 24].
To our knowledge, no investigations have been performed regarding cholesterol catabolism in voluntary apnea divers. We hypothesize that short time hypoxemia leads to altered triglyceride, cholesterol, and oxysterol plasma levels in voluntary apnea divers.
Aim of this explorative single-center prospective study is to identify effects on cholesterol and oxysterols after a short-time maximal apnea, to compare results with long-term data of hypoxia on circulating blood lipid levels and to further improve knowledge of pathophysiological processes affecting the cardiovascular system in apneic diving.
Materials and methods
Ethics
The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board (Ethics Committee, Medical Faculty, University Hospital Bonn (373/13)). This study is in accordance with the ethical standards of the Institutional and/or National research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Collective
Ten athletes (eight men and two women) had to perform apnea in the morning for as long as possible under dry conditions in a horizontal position. A prerequisite was a period of fasting from caffeine containing drinks and food for at least 8 h prior to examination. A detailed setting and collective description was published previously (8). For measurements of blood lipid levels, withdrawal of venous blood was conducted before apnea, immediately after apnea and 0.5 h after apnea.
Methods
Heart rate and SpO2 were raised by Expression MR 400 (Invivo, Gainsville, FL, USA). Blood was immediately centrifuged and stored until analysis (−80 °C). Analyses were performed in batches. Cholesterol, triglycerides, high-density lipoprotein (HDL)-cholesterol, and LDL-cholesterol were determined photometrically (cobas® c702, Roche Diagnostics, Mannheim, Germany), while APOA1, APOB and Lipoprotein (a) were determined with turbidimetric immunoassays (cobas® c502, Roche Diagnostics, Mannheim, Germany).
Serum concentrations of cholesterol were quantified using gas chromatography (GC)-flame ionization detection (FID) with 5α-cholestane as internal standard [25, 26]. The serum concentrations of total oxysterols 4β-, 7α, 7β, 24S- and 27-hydroxycholesterol as well as 7-ketocholesterol and cholestane-3β, 5α, 6β-triol were quantified by an isotope dilution GC-MS-SIM methodology using the corresponding deuterium labelled oxysterols as internal standards [26]. All sterols and oxysterols were corrected for cholesterol as measured in the same sample (R_sterols) by GC-FID.
Statistics
Mean values and standard deviations (SD) were calculated. Correlations between the differences of the individual time points for serum concentrations of lipoproteins and total apnea time were estimated and tested using Spearman’s rank correlation test. Pairwise comparison of absolute plasma levels of cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, APOA1, APOB, lipoprotein (a), and pairwise comparison of absolute and cholesterol corrected plasma levels of oxysterols 4β-, 7α, 7β, 24S-, 27-hydroxycholesterol, 7-ketocholesterol and cholestane-3β, 5α, 6β-triol from the different sampling dates was conducted using a robust mixed linear model with patient as random factor. The same model was used to consider the course of the ratios of 24S-OHC and 27-OHC to cholesterol (R_24SOHC and R_27-OHC) and 24S-OHC to 27-OHC. All statistical tests were performed using GraphPad Prism (GraphPad software, version 8.00, San Diego, CA, USA). Stata 14.2 (StataCorp, College Station, TX, USA) was applied for mixed linear modelling and trend calculations. The α-level was set at 0.05. A p-value <0.05 was considered statistically significant.
Results
Mean age of divers was 41 ± 1 years. The mean total apnea time was 317 s [±111 SD] and the mean minimal peripheral oxygen saturation (SpO2) was 79 [±12 SD] [7]. Mean values, Standard error of the mean (SEM), mean differences, 95%- confidence intervals (CI), p-values and slopes for different time points for (apo)lipoproteins, triglycerides and total cholesterol (enzymatically) are presented in Table 1, for cholesterol (GC-FID) and absolute oxysterol concentrations in Table 2 and for oxysterols corrected for cholesterol measured by GC-FID in Table 3.
Differences between time points for (apo)lipoproteins, triglycerides and total cholesterol as measured enzymatically.
| ApoAI, g/L | ApoB, g/L | Lp(a), mg/L | TGs, mg/dL | HDL-C, mg/dL | LDL-C, mg/dL | Cenz., mg/dL | |
|---|---|---|---|---|---|---|---|
| Before (T1) | 1.41 (0.09)a | 0.96 (0.08) | 35 (11)a | 96 (15) | 55 (5.3)a | 123 (12) | 195 (12) |
| After apnoe (T2) | 1.36 (0.08) | 0.93 (0.07) | 35 (11) | 95 (14) | 54 (4.7) | 121 (11) | 190 (12) |
| 0.5 h after apnoe (T3) | 1.34 (0.06) | 0.92 (0.08) | 34 (11) | 89 (14) | 53 (4.4) | 119 (11) | 187 (12) |
|
|
|||||||
| T1 vs. T2 | |||||||
|
|
|||||||
| Mean difference | −0.04 (0.03) | −0.03 (0.02) | −0.08 (0.84) | −0.9 (3.0) | −1.4 (1.0) | −2.5 (2,2) | −4.9 (3.0) |
| 95%CI | −0.10 to 0.02 | −0.06 to 0.001 | −1.72 to 1.57 | −6.8 to 5.0 | −3.36 to 0.56 | −6.8 to 1.8 | −11 to 0.94 |
| Ppw | 0.17 | 0.06 | 0.92 | 0.77 | 0.16 | 0.25 | 0.10 |
|
|
|||||||
| T1 vs. T3 | |||||||
|
|
|||||||
| Mean difference | −0.06 (0.04) | −0.04 (0.01) | −0.92 (0.57) | −7.1 (3.2) | −2.2 (1.06) | −4.3 (2.0) | −8.4 (2.7) |
| 95%CI | −0.14 to −0.01 | −0.07 to −0.02 | −2.0 to 0.21 | −13.3 to −0.87 | −4.28 to −0.12 | −8.2 to −0.39 | −14 to −3.2 |
| Ppw | 0.10 | 0.001 | 0.11 | <0.05 | <0.05 | <0.05 | <0.01 |
|
|
|||||||
| T2 vs. T3 | |||||||
|
|
|||||||
| Mean difference | −0.02 (0.02) | −0.01 (0.01) | −0.84 (0.55) | −6.2 (3.0) | −0.8 (0.39) | −1.8 (0.55) | −3.5 (0.91) |
| 95%CI | −0.06 to 0.02 | −0.03 to 0.01 | −1.9 to 0.25 | −12.1 to −0.27 | −1.56 to 0.04 | −29 to −0.71 | −5.2 to −1.7 |
| Ppw | 0.28 | 0.17 | 0.13 | <0.05 | <0.05 | 0.001 | <0.001 |
| Slope T1 to T3 | −0.02 | −0.014 | −0.32 | −2.47 | −0.69 | −1.4 | −2.7 |
| PT1_T3 | 0.10 | 0.001 | 0.05 | <0.05 | <0.05 | <0.05 | <0.001 |
-
The Table shows mean values, standard error of the mean (SEM), mean differences, 95% confidence intervals (CI), p-values and slopes for different time points for (apo)lipoproteins, triglycerides and total cholesterol as measured enzymatically. Ppw expresses the significance of the effect of apnoe pairwise comparing different sampling dates using a robust mixed linear model with subjects as random factor. PT1_T3 expresses the significance of the effect of apnoe within 0.5 h using a robust mixed linear model with subjects as random factor. aMean (S.E.M.). 95%CI, 95% confidence interval. HDL-C (high-density lipoprotein -cholesterol), LDL-C (low-density lipoprotein-cholesterol), APOA1 (apolipoprotein 1), APOB (apolipoprotein B), Lp (a) (lipoprotein a), Cenz. (cholesterol enzymatically), T1=baseline concentration, T2=post apnea and T3=0.5 post apnea.
Differences between time points for cholesterol as measured by GC-FID (CFID) and absolute oxysterol concentrations.
| CFID, mg/dL | 4β-OHC, ng/mL | 7α-OHC, ng/mL | 7β-OHC, ng/mL | 24S-OHC, ng/mL | 27-OHC, ng/mL | 7-KC, ng/mL | C-triol, ng/mL | |
|---|---|---|---|---|---|---|---|---|
| Before (T1) | 198 (15)a | 19.5 (3.1) | 48.6 (9.2) | 2.00 (0.18) | 41.6 (3.04) | 159 (11) | 127 (9.0) | 3.72 (0.18) |
| After apnoe (T2) | 187 (14) | 18.6 (2.8) | 46.1 (9.1) | 1.94 (0.15) | 41.2 (2.8) | 153 (8.6) | 120 (5.4) | 3.71 (0.14) |
| 0.5 h after apnoe (T3) | 181 (14) | 17.8 (2.6) | 44.1 (8.8) | 1.81 (0.18) | 38.4 (2.63) | 142 (8.3) | 109 (6.6) | 3.75 (0.18) |
|
|
||||||||
| T1 vs. T2 | ||||||||
|
|
||||||||
| Mean difference | −11.2 (4.9) | −0.84 (0.88) | −2.5 (2.1) | −0.07 (0.09) | −0.4 (1.5) | −6.1 (6.2) | −6.6 (9.0) | −0.12 (0.20) |
| 95%CI | −20.7 to 1.6 | −2.6 to 0.9 | −6.5 to 1.5 | −0.25 to 0.11 | −3.3 to 2.5 | −18 to 6.0 | −24.1 to 11.0 | −0.41 to 0.39 |
| Ppw | <0.05 | 0.34 | 0.22 | 0.46 | 0.79 | 0.32 | 0.46 | 0.95 |
|
|
||||||||
| T1 vs. T3 | ||||||||
|
|
||||||||
| Mean difference | −16.3 (4.7) | −1.7 (1.0) | −4.5 (2.1) | −0.19 (0.10) | −3.2 (1.6) | −17.1 (7.4) | −17.7 (7.7) | 0.03 (0.17) |
| 95%CI | −25.6 to −6.9 | −3.7 to 0.3 | −8.7 to −0.3 | −0.38 to 0.0006 | −6.4 to −0.002 | −31.5 to −2.7 | −32.9 to −2.5 | −0.31 to 0.36 |
| Ppw | <0.001 | 0.09 | <0.05 | 0.051 | 0.05 | <0.05 | <0.05 | 0.87 |
|
|
||||||||
| T2 vs. T3 | ||||||||
|
|
||||||||
| Mean difference | −5.1 (1.5) | −0.86 (0.72) | −2.0 (1.0) | −0.12 (0.05) | −2.8 (1.2) | −11 (3.6) | −11.1 (1.2) | −0.04 (0.16) |
| 95%CI | −8.0 to −2.2 | −2.3 to 0.55 | −4.0 to 0.003 | −0.23 to −0.016 | −5.1 to −0.47 | −18 to −3.9 | −27.6 to 5.4 | −0.28 to 0.36 |
| Ppw | 0.19 | 0.23 | 0.05 | <0.05 | <0.02 | <0.05 | 0.19 | 0.80 |
| Slope T1 to T3 | −5.0 | −0.54 | −1.4 | −0.06 | −1.11 | −5.7 | −5.9 | 0.01 |
| PT1_T3 | <0.001 | 0.09 | <0.05 | <0.05 | <0.03 | <0.05 | <0.02 | 0.83 |
-
The Table shows mean values, standard error of the mean (SEM), mean differences, 95%- confidence intervals (CI), p-values and slopes for different time points for cholesterol (GC) and absolute oxysterol concentrations Ppw expresses the significance of the effect of apnoe pairwise comparing different sampling dates using a robust mixed linear model with subjects as random factor. PT1_T3 expresses the significance of the effect of apnoe within 0.5 h using a robust mixed linear model with subjects as random factor. aMean (S.E.M.). 95%CI, 95% confidence interval. GC (gas-chromatography), OHC (hydroxy-cholesterol), KC (ketocholesterol). T1=baseline concentration, T2=post apnea and T3=0.5 post apnea.
Differences between time points for oxysterols corrected for cholesterol measured by GC-FID (R_oxysterols).
| R_4β-OHC, ng/mg | R_7α-OHC, ng/mg | R_7β−OHC, ng/mg | R_24S-OHC, ng/mg | R_27-OHC, ng/mg | R_7-KC, ng/mg | R_C-triol, mg/dL | |
|---|---|---|---|---|---|---|---|
| Before (T1) | 9.7 (1.0) | 23.8 (3.3) | 1.02 (0.05) | 21.4 (0.83) | 83 (6.0) | 66.4 (5.1) | 1.96 (0.13) |
| After apnoe (T2) | 9.9 (1.1) | 25.1 (3.4) | 1.05 (0.05) | 22.4 (1.18) | 85 (5.8) | 67 (4.7) | 2.07 (0.14) |
| 0.5 h after apnoe (T3) | 9.7 (1.0) | 24.6 (3.4) | 0.99 (0.05) | 21.4 (1.02) | 81 (5.4) | 62.5 (5.1) | 2.17 (0.18) |
|
|
|||||||
| T1 vs. T2 | |||||||
|
|
|||||||
| Mean difference | 0.19 (0.28) | 1.3 (0.84) | 0.03 (0.05) | 1 (0.60) | 1.8 (1.9) | 0.6 (4.2) | 0.11 (0.11) |
| 95%CI | −0.36 to 0.73 | −0.35 to 2.9 | −0.07 to 0.13 | −5.8 to 14 | −2.0 to 5.6 | −7.7 to 8.9 | −0.11 to 0.32 |
| Ppw | 0.50 | 0.12 | 0.58 | 0.09 | 0.35 | 0.89 | 0.33 |
|
|
|||||||
| T1 vs. T3 | |||||||
|
|
|||||||
| Mean difference | 0.01 (0.23) | 0.8 (0.68) | −0.02 (0.06) | −0.00 (0.63) | −1.7 (2.0) | −3.9 (3.2) | 0.21 (0.09) |
| 95%CI | −0.43 to 0.45 | −0.53 to 2.13 | −0.13 to 0.09 | −4.2 to 25 | −5.6 to 2.2 | −10 to 2.3 | 0.02 to 0.39 |
| Ppw | 0.97 | 0.24 | 0.69 | 1.0 | 0.39 | 0.22 | <0.05 |
|
|
|||||||
| T2 vs. T3 | |||||||
|
|
|||||||
| Mean difference | −0.18 (0.32) | −0.5 (0.56) | −0.05 (0.03) | −1 (0.56) | −3.5 (1.8) | −4.5 (5.3) | 0.10 (0.11) |
| 95%CI | −0.82 to 0.45 | −1.6 to 0.6 | −0.11 to 0.008 | −2.1 to 0.09 | −7.0 to −0.003 | −14.9 to 5.9 | −0.11 to 0.31 |
| Ppw | 0.58 | 0.38 | 0.09 | 0.07 | 0.05 | 0.40 | 0.36 |
| Slope T1 to T3 | 0.01 | 0.19 | −0.01 | −0.71 | −0.74 | −1.4 | 0.07 |
| PT1_T3 | 0.90 | 0.34 | 0.55 | 0.73 | 0.25 | 0.22 | <0.05 |
-
The Table shows mean values, standard error of the mean (SEM), mean differences, 95%- confidence intervals (CI), p-values and slopes for different time points for 3 oxysterols corrected for cholesterol measured by GC-FID (R_Oxysterols). Ppw expresses the significance of the effect of apnoe pairwise comparing different sampling dates using a robust mixed linear model with subjects as random factor. PT1_T3 expresses the significance of the effect of apnoe within 0.5 h using a robust mixed linear model with subjects as random factor. aMean (S.E.M.). 95%CI, 95% confidence interval. GC (gas-chromatography), OHC (hydroxy-cholesterol), KC (ketocholesterol). T1=baseline concentration, T2=post apnea and T3=0.5 post apnea.
Spearman’s correlation analysis between apnea time and differences in lipoprotein cholesterol concentrations between the individual time points showed statistically significant correlations for HDL (T2-T1; R=0.716, p=0.024), LDL (T2-T1; R=0.787, p=0.009) and LDL (T3-T2; R=0.699, p<0.029).
Discussion
To our knowledge, no short-time hypoxia expositions, especially with regard to plasma triglycerides, lipoprotein and cholesterol derived oxysterol levels, have been performed in voluntary apnea divers to date. After a single maximal dry apnea, we observed significantly reduced levels of apolipoprotein B, lipids (triglycerides, cholesterol, HDL, LDL) and oxysterols (7β-OHC, 24-OHC, 27-OHC and 7-KC). Nevertheless, GC-cholesterol corrected plasma levels showed no significant changes after a short post-apnea time except for a statistically significant elevation of the 3β5a, 6β-cholestantriol ratio.
In contrast to 6 h hypoxia in fasting healthy young men as published by Morin et al. we indeed found a reduction in triglycerides and low-density lipoproteins after 0.5 h, eventually resulting in lower plasma sterols and oxysterols [15]. In ten elderly male subjects with chronic stable angina, no changes in fasting apolipoprotein, lipoprotein, and lipid levels before and after carbon monoxide hypoxia exposures were observed [27]. Data from rodent studies also showed a wide range of increasing triglyceride levels after different hypoxia times [11]. In contrast to these literature observations, we used a different hypoxia model while studying short post-apnea times after a single maximal dry apnea in healthy trained divers. Interestingly, experiments with single hypoxia exposures in mice resulted in increased triglyceride levels via decreasing plasma lipoprotein clearance, but experiments were carried out below thermoneutrality [28]. When performing experiments under thermoneutral conditions, no effects on plasma triglyceride levels were observed [29]. It is known that under acute hypoxia, sympathetic nervous system arousal induces adipose tissue lipolysis, but whether hypoxia affects fasting triglyceride levels in humans is still controversially discussed [13]. In a rodent model, rats exposed to continuous low-pressure oxygen showed reduced levels of, inter alia, LDL-cholesterol, triglycerides and cholesterol, whereas LDL-cholesterol values were higher than in the control group [30]. In human monocyte-derived macrophages under hypoxia, the intracellular metabolism of LDL cholesterol was affected, and the authors speculate that hypoxia might adjust cholesterol/protein transport in the cytosol [31].
In our short post-apnea time setting, we could show that hypoxemia lead to reduced plasma levels of apolipoprotein B, triglycerides, cholesterol, HDL, LDL and oxysterols and an increased cholestane-3β, 5α, 6β-triol ratio in voluntary apnea divers. Future follow-up studies should expand these results after repetitive apnea times. Long term follow-up with specific focus on the cardiovascular system could improve recreational apnea divers care and deepen knowledge of long term effects of apneic diving.
Limitations
The present study provides a basis for investigating the potential pathophysiological effects on lipid metabolism in apnea divers. Therefore, this study is to be regarded as exploratory. Due to its limitations, further studies based on this are called for. However, published studies to date had comparable collective sizes [32, 33].
Conclusions
Our study deepens insights into triglyceride, cholesterol and oxysterol plasma levels after a single short time hypoxemia under dry conditions in voluntary apnea divers. In physical examinations, cardiovascular risk factors should be carefully evaluated.
Important note
Experiments were carried out under strict supervision and according to the highest safety standards. Continuous monitoring by an emergency physician/anesthetist took place. Do not to replicate these experiments independently.
Acknowledgments
We are grateful to Anja Kerksiek for her technical assistance in measuring the GC-FID and GC-MS parameters.
-
Research funding: None declared.
-
Author contributions: RDP, BSW, LE: Conceptualization, Investigation. RDP,BSW,MR,FS,DL,LE: Wrote main manuscript, Data acquisition. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: RDP received lectures honoraria from Roche Diagnostics and Siemens Healthineers. The other authors declare no conflicts of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The research related to human use has been complied with all the relevant national regulations, institutional policies and in accordance the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board (Ethics Committee, Medical Faculty, University Hospital Bonn (373/13)). This study is in accordance with the ethical standards of the Institutional and/or National Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
-
Trial registration: DRKS00021448 , retrospectively registered.
References
1. Moir, ME, Klassen, SA, Al-Khazraji, BK, Woehrle, E, Smith, SO, Matushewski, BJ, et al.. Impaired dynamic cerebral autoregulation in trained breath-hold divers. J Appl Physiol (1985) 2019;126:1694–700. https://doi.org/10.1152/japplphysiol.00210.2019.Search in Google Scholar PubMed PubMed Central
2. Elia, A, Gennser, M, Harlow, PS, Lees, MJ. Physiology, pathophysiology and (mal)adaptations to chronic apnoeic training: a state-of-the-art review. Eur J Appl Physiol 2021;121:1543–66. https://doi.org/10.1007/s00421-021-04664-x.Search in Google Scholar PubMed PubMed Central
3. Bouten, J, Bourgois, JG, Boone, J. Hold your breath: peripheral and cerebral oxygenation during dry static apnea. Eur J Appl Physiol 2020;120:2213–22. https://doi.org/10.1007/s00421-020-04445-y.Search in Google Scholar PubMed
4. Dolscheid-Pommerich, RC, Stoffel-Wagner, B, Alberts, J, Fimmers, R, Eichhorn, L. Hematologic changes after short term hypoxia in non-elite apnea divers under voluntary dry apnea conditions. PLoS One 2020;15:e0237673. https://doi.org/10.1371/journal.pone.0237673.Search in Google Scholar PubMed PubMed Central
5. Oh, YJ, Jung, JY, Kim, SS, Chae, KS, Rhu, J, Lee, C. The association of kidney function with repetitive breath-hold diving activities of female divers from Korea, Haenyeo. BMC Nephrol 2017;18:75. https://doi.org/10.1186/s12882-017-0481-1.Search in Google Scholar PubMed PubMed Central
6. Eichhorn, L, Doerner, J, Luetkens, JA, Lunkenheimer, JM, Dolscheid-Pommerich, RC, Erdfelder, F, et al.. Cardiovascular magnetic resonance assessment of acute cardiovascular effects of voluntary apnoea in elite divers. J Cardiovasc Magn Reson 2018;20:40. https://doi.org/10.1186/s12968-018-0455-x.Search in Google Scholar PubMed PubMed Central
7. Dolscheid-Pommerich, RC, Weikert, J, Reinicke, M, Fimmers, R, Stoffel-Wagner, B, Erdfelder, F, et al.. Changes in PUFA and eicosanoid metabolism during/after apnea diving: a prospective single-center study. Undersea Hyperb Med 2020;47:539–49. https://doi.org/10.22462/010.12.2020.2.Search in Google Scholar
8. Eichhorn, L, Erdfelder, F, Kessler, F, Dolscheid-Pommerich, RC, Zur, B, Hoffmann, U, et al.. Influence of apnea-induced hypoxia on catecholamine release and cardiovascular dynamics. Int J Sports Med 2017;38:85–91. https://doi.org/10.1055/s-0042-107351.Search in Google Scholar PubMed
9. Drager, LF, Jun, J, Polotsky, VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010;17:161–5. https://doi.org/10.1097/med.0b013e3283373624.Search in Google Scholar
10. Drager, LF, Yao, Q, Hernandez, KL, Shin, MK, Bevans-Fonti, S, Gay, J, et al.. Chronic intermittent hypoxia induces atherosclerosis via activation of adipose angiopoietin-like 4. Am J Respir Crit Care Med 2013;188:240–8. https://doi.org/10.1164/rccm.201209-1688oc.Search in Google Scholar PubMed PubMed Central
11. Morin, R, Goulet, N, Mauger, JF, Imbeault, P. Physiological responses to hypoxia on triglyceride levels. Front Physiol 2021;12:730935. https://doi.org/10.3389/fphys.2021.730935.Search in Google Scholar PubMed PubMed Central
12. Mahat, B, Chassé, É, Mauger, JF, Imbeault, P. Effects of acute hypoxia on human adipose tissue lipoprotein lipase activity and lipolysis. J Transl Med 2016;14:212. https://doi.org/10.1186/s12967-016-0965-y.Search in Google Scholar PubMed PubMed Central
13. Mahat, B, Chassé, É, Lindon, C, Mauger, JF, Imbeault, P. No effect of acute normobaric hypoxia on plasma triglyceride levels in fasting healthy men. Appl Physiol Nutr Metabol 2018;43:727–32. https://doi.org/10.1139/apnm-2017-0505.Search in Google Scholar PubMed
14. Mauger, JF, Chassé, É, Mahat, B, Lindon, C, Bordenave, N, Imbeault, P. The effect of acute continuous hypoxia on triglyceride levels in constantly fed healthy men. Front Physiol 2019;10:752. https://doi.org/10.3389/fphys.2019.00752.Search in Google Scholar PubMed PubMed Central
15. Morin, R, Mauger, JF, Amaratunga, R, Imbeault, P. The effect of acute intermittent hypoxia on postprandial triglyceride levels in humans: a randomized crossover trial. J Transl Med 2021;19:268. https://doi.org/10.1186/s12967-021-02933-z.Search in Google Scholar PubMed PubMed Central
16. Ginsberg, HN, Packard, CJ, Chapman, MJ, Borén, J, Aguilar-Salinas, CA, Averna, M, et al.. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J 2021;42:ehab551. https://doi.org/10.1093/eurheartj/ehab551.Search in Google Scholar PubMed PubMed Central
17. Chapman, MJ, Ginsberg, HN, Amarenco, P, Andreotti, F, Borén, J, Catapano, AL, et al.. European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J 2011;32:1345–61. https://doi.org/10.1093/eurheartj/ehr112.Search in Google Scholar PubMed PubMed Central
18. Packard, C, Chapman, MJ, Sibartie, M, Laufs, U, Masana, L. Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges. Heart 2021;107:1369–75. https://doi.org/10.1136/heartjnl-2020-318760.Search in Google Scholar PubMed PubMed Central
19. Ravi, S, Duraisamy, P, Krishnan, M, Martin, LC, Manikandan, B, Raman, T, et al.. An insight on 7- ketocholesterol mediated inflammation in atherosclerosis and potential therapeutics. Steroids 2021;172:108854. https://doi.org/10.1016/j.steroids.2021.108854.Search in Google Scholar PubMed
20. Brown, AJ, Sharpe, LJ, Rogers, MJ. Oxysterols: from physiological tuners to pharmacological opportunities. Br J Pharmacol 2021;178:3089–103. https://doi.org/10.1111/bph.15073.Search in Google Scholar PubMed
21. Kloudova-Spalenkova, A, Holy, P, Soucek, P. Oxysterols in cancer management: from therapy to biomarkers. Br J Pharmacol 2021;178:3235–47. https://doi.org/10.1111/bph.15273.Search in Google Scholar PubMed
22. Sottero, B, Rossin, D, Staurenghi, E, Gamba, P, Poli, G, Testa, G. Omics analysis of oxysterols to better understand their pathophysiological role. Free Radic Biol Med 2019;144:55–71. https://doi.org/10.1016/j.freeradbiomed.2019.05.026.Search in Google Scholar PubMed
23. Testa, G, Rossin, D, Poli, G, Biasi, F, Leonarduzzi, G. Implication of oxysterols in chronic inflammatory human diseases. Biochimie 2018;153:220–31. https://doi.org/10.1016/j.biochi.2018.06.006.Search in Google Scholar PubMed
24. Eichhorn, L, Dolscheid-Pommerich, R, Erdfelder, F, Ayub, MA, Schmitz, T, Werner, N, et al.. Sustained apnea induces endothelial activation. Clin Cardiol 2017;40:704–9. https://doi.org/10.1002/clc.22720.Search in Google Scholar PubMed PubMed Central
25. Mackay, DS, Jones, PJ, Myrie, SB, Plat, J, Lutjohann, D. Considerations for the harmonization of non-cholesterol sterol bio-analysis. J Chromatogr, B: Anal Technol Biomed Life Sci 2014;957:116–22. https://doi.org/10.1016/j.jchromb.2014.02.052.Search in Google Scholar PubMed
26. Sosic-Jurjevic, B, Lutjohann, D, Renko, K, Filipovic, B, Radulovic, N, Ajdzanovic, V, et al.. The isoflavones genistein and daidzein increase hepatic concentration of thyroid hormones and affect cholesterol metabolism in middle-aged male rats. J Steroid Biochem Mol Biol 2019;190:1–10.10.1016/j.jsbmb.2019.03.009Search in Google Scholar PubMed
27. Leaf, DA, Kleinman, MT. Acute exposure to carbon monoxide does not affect plasma lipids, lipoproteins, and Apolipoproteins. Angiology 1996;47:337–41. https://doi.org/10.1177/000331979604700403.Search in Google Scholar PubMed
28. Jun, JC, Shin, MK, Yao, Q, Bevans-Fonti, S, Poole, J, Drager, LF, et al.. Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice. Am J Physiol Endocrinol Metab 2012;303:E377–88. https://doi.org/10.1152/ajpendo.00641.2011.Search in Google Scholar PubMed PubMed Central
29. Jun, JC, Shin, MK, Yao, Q, Devera, R, Fonti-Bevans, S, Polotsky, VY. Thermoneutrality modifies the impact of hypoxia on lipid metabolism. Am J Physiol Endocrinol Metab 2013;304:E424–35. https://doi.org/10.1152/ajpendo.00515.2012.Search in Google Scholar PubMed PubMed Central
30. Ruixia, Z, Chuanchuan, L, Lu, G, Shuang, M, Qiang, Z, Xiaofang, T, et al.. Studies on the effects of hypothermia combined with hypoxia on rat skeletal muscle and lipid metabolism based on AMPK/PGC1alpha pathway. J Orthop Surg Res 2021;16:712. https://doi.org/10.1186/s13018-021-02861-0.Search in Google Scholar PubMed PubMed Central
31. Matsumoto, K, Taniguchi, T, Fujioka, Y, Shimizu, H, Ishikawa, Y, Yokoyama, M. Effects of hypoxia on cholesterol metabolism in human monocyte-derived macrophages. Life Sci 2000;67:2083–91. https://doi.org/10.1016/s0024-3205(00)00794-3.Search in Google Scholar
32. Cialoni, D, Brizzolari, A, Sponsiello, N, Lancellotti, V, Lori, C, Bosco, G, et al.. Serum cardiac and skeletal muscle marker changes in repetitive breath-hold diving. Sports Med Open 2021;7:58. https://doi.org/10.1186/s40798-021-00349-z.Search in Google Scholar PubMed PubMed Central
33. Kjeld, T, Isbrand, AB, Linnet, K, Zerahn, B, Højberg, J, Hansen, EG, et al.. Extreme hypoxia causing brady-arrythmias during apnea in elite breath-hold divers. Front Physiol 2021;12:712573. https://doi.org/10.3389/fphys.2021.712573.Search in Google Scholar PubMed PubMed Central
© 2022 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- Original Articles
- Automated assessment of immunofixations with deep neural networks
- Non-invasive prenatal paternity testing using mini-STR-based next-generation sequencing: a pilot study
- The effect of short post-apnea time on plasma triglycerides, lipoprotein and cholesterol derived oxysterols levels
- Assessment of the diagnostic ability of RIFLE and SOFA scoring systems in comparison with protein biomarkers in acute kidney injury
- Diagnostic value of long noncoding RNA LINC01060 in gastric cancer
- Novel GLDC variants causing nonketotic hyperglycinemia in Chinese patients
- Congress Abstracts
- German Congress of Laboratory Medicine: 17th Annual Congress of the DGKL and 4th Symposium of the Biomedical Analytics of the DVTA e.V.
Articles in the same Issue
- Frontmatter
- Original Articles
- Automated assessment of immunofixations with deep neural networks
- Non-invasive prenatal paternity testing using mini-STR-based next-generation sequencing: a pilot study
- The effect of short post-apnea time on plasma triglycerides, lipoprotein and cholesterol derived oxysterols levels
- Assessment of the diagnostic ability of RIFLE and SOFA scoring systems in comparison with protein biomarkers in acute kidney injury
- Diagnostic value of long noncoding RNA LINC01060 in gastric cancer
- Novel GLDC variants causing nonketotic hyperglycinemia in Chinese patients
- Congress Abstracts
- German Congress of Laboratory Medicine: 17th Annual Congress of the DGKL and 4th Symposium of the Biomedical Analytics of the DVTA e.V.